Johnson & Johnson’s JNJ stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since mid-June. It ...

Johnson & Johnson’s (NYSE: JNJ) stock chart is sending a clear signal that contrasts sharply with the persistent hum of ...

If you are standing at a crossroads with Johnson & Johnson's stock, you are not alone. The past several months have given ...

Johnson & Johnson (NYSE:JNJ) is a global healthcare company that researches, develops, and manufactures a wide range of ...

John C. Reed, Executive Vice President, Innovative Medicine and R&D of Johnson & Johnson ( JNJ 0.17%), executed an open market sale of 19,137 shares as disclosed in a Form 4 filed July 18, 2025.

Analysts have recently evaluated Johnson & Johnson and provided 12-month price targets. The average target is $180.11, accompanied by a high estimate of $200.00 and a low estimate of $167.00. This ...

Asad Haider from Goldman Sachs set a target price of $172.0 on 04/09/2025 $JNJ Congressional Stock Trading Members of Congress have traded $JNJ stock 22 times in the past 6 months.

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price is back in rally mode. It is still early in the game, but the Q2 ...

The company has a 50 day moving average price of $154.29 and a 200-day moving average price of $155.05. Johnson & Johnson has a fifty-two week low of $140.68 and a fifty-two week high of $169.99.

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE:JNJ) stock price is back in rally mode. It is still early in the game, but the Q2 ...